MARINA KONOPLEVA to Hydroxamic Acids
This is a "connection" page, showing publications MARINA KONOPLEVA has written about Hydroxamic Acids.
Connection Strength
0.143
-
Phase II trial of vorinostat with idarubicin and cytarabine for patients with newly diagnosed acute myelogenous leukemia or myelodysplastic syndrome. J Clin Oncol. 2012 Jun 20; 30(18):2204-10.
Score: 0.084
-
Novel role of HDAC inhibitors in AML1/ETO AML cells: activation of apoptosis and phagocytosis through induction of annexin A1. Cell Death Differ. 2007 Aug; 14(8):1443-56.
Score: 0.059